Resultados da busca - Marjukka Myllärniemi

  • Mostrando 1 - 19 resultados de 19
Refinar Resultados
  1. 1
    Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine

    Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine por Marjukka Myllärniemi, Riitta Kaarteenaho

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Extracellular Superoxide Dismutase in Pulmonary Fibrosis

    Extracellular Superoxide Dismutase in Pulmonary Fibrosis por Fei Gao, Vuokko L. Kinnula, Marjukka Myllärniemi, Tim D. Oury

    Publicado em 2007
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD

    8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD por Vuokko L. Kinnula, Helen Ilumets, Marjukka Myllärniemi, A. Sovijärvi, Paula Rytilä

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data

    Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data por Jaana Kaunisto, Eija‐Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Marjukka Myllärniemi

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    End-of-life care of patients with idiopathic pulmonary fibrosis

    End-of-life care of patients with idiopathic pulmonary fibrosis por Kaisa Rajala, Juho T. Lehto, Maiju Saarinen, Eva Sutinen, Tiina Saarto, Marjukka Myllärniemi

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life

    Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life por Kaisa Rajala, Juho T. Lehto, Eva Sutinen, Hannu Kautiainen, Marjukka Myllärniemi, Tiina Saarto

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD

    Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD por Paula Rytilä, Tiina Rehn, Helen Ilumets, Annamari Rouhos, Anssi Sovijärvi, Marjukka Myllärniemi, Vuokko L. Kinnula

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β

    Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β por Sari Mäkelä, Hanna Savolainen, Einari Aavik, Marjukka Myllärniemi, Leena Strauss, E Taskinen, Jan-Ακε Gustafsson, P Häyry

    Publicado em 1999
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis

    Bone Morphogenetic Protein-4 Inhibitor Gremlin Is Overexpressed in Idiopathic Pulmonary Fibrosis por Katri Koli, Marjukka Myllärniemi, Kirsi Vuorinen, Kaisa Salmenkivi, Merja J. Ryynänen, Vuokko L. Kinnula, Jorma Keski‐Oja

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

    Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo por Chang Li, Veronika Rezov, Emmi I. Joensuu, Ville Vartiainen, Mikko Rönty, Miao Yin, Marjukka Myllärniemi, Katri Koli

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry

    Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry por Jaana Kaunisto, Eija‐Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Hannu Kankaanranta, Katri Koli, Tero Vahlberg, Marjukka Myllärniemi

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis

    Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis por Kati Mäkelä, Mikko I. Mäyränpää, Hanna-Kaisa Sihvo, Paula Bergman, Eva Sutinen, Hely Ollila, Riitta Kaarteenaho, Marjukka Myllärniemi

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis

    Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis por Marjukka Myllärniemi, Pamela Lindholm, Merja J. Ryynänen, Corrine R. Kliment, Kaisa Salmenkivi, Jorma Keski‐Oja, Vuokko L. Kinnula, Tim D. Oury, Katri Koli

    Publicado em 2007
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events

    Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events por Elisabeth Bendstrup, Wim Wuyts, Tiago M. Alfaro, Nazia Chaudhuri, Robin Cornelissen, Michael Kreuter, Kirsten Melgaard Nielsen, Anna‐Marie Bloch Münster, Marjukka Myllärniemi, Claudia Ravaglia, Tim Vanuytsel, Marlies Wijsenbeek

    Publicado em 2018
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  15. 15
    Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis

    Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis por Jaana Kaunisto, Katariina Kelloniemi, Eva Sutinen, Ulla Hodgson, Anneli Piilonen, Riitta Kaarteenaho, Riitta Mäkitaro, Minna Purokivi, Elisa Lappi‐Blanco, S. Saarelainen, Hannu Kankaanranta, A. Mursu, Merja Kanervisto, E-R. Salomaa, Marjukka Myllärniemi

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics

    Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics por Juulia Partanen, Paavo Häppölä, Wei Zhou, Arto Lehistö, Mari Ainola, Eva Sutinen, Richard J. Allen, Amy Stockwell, Olivia C. Leavy, Justin M. Oldham, Beatriz Guillén‐Guío, Nancy J. Cox, Jibril Hirbo, David A. Schwartz, Tasha E. Fingerlin, Carlos Flores, Imre Noth, Brian L. Yaspan, Gisli Jenkins, Louise V. Wain, Samuli Ripatti, Matti Pirinen, Tarja Laitinen, Riitta Kaarteenaho, Marjukka Myllärniemi, Mark J. Daly, Jukka Koskela

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial

    Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial por Olli Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi M. J. Mustonen, Ilkka Kalliala, Hanna Ansakorpi, Hanna‐Riikka Kreivi, Pauliina Kuutti, Juuso Paajanen, Seppo Parkkila, Erja‐Leena Paukkeri, Markus Perola, Negar Pourjamal, Andreas Renner, Tuomas Rosberg, Taija Rutanen, Joni Savolainen, Tero Ala‐Kokko, Jaakko Antonen, Jutta Delany, Heikki Ekroos, Riina Hankkio, Mia Haukipää, Iivo Hetemäki, Pia Holma, Ville Holmberg, Ville Jalkanen, Jenni Jouppila, Toni Jämsänen, Juuso Järventie, Petrus Järvinen, Heikki Kauma, Tuomas P. Kilpeläinen, Riitta Komulainen, Ilari Kuitunen, Satu Lamminmäki, Tiina Mattila, Marjukka Myllärniemi, Laura K. Mäkinen, Jarkko Mäntylä, Gitte Määttä, Joni Niskanen, Taina Nykänen, Miro Nyqvist, Terhi Partanen, Riitta-Liisa Patovirta, Emmi Puusti, Emma Reponen, Sari Risku, Mari Saalasti, Päivi Salonen, Marjatta U. Sinisalo, Katariina Sivenius, Petrus Säilä, Susanna Tuominen, Jari Haukka, Gordon Guyatt, Kari A.O. Tikkinen

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

    Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study por Toby M. Maher, Susanne Stowasser, Yasuhiko Nishioka, Eric S. White, Vincent Cottin, Imre Noth, Moisés Selman, Klaus Röhr, Andreas Michael, Carina Ittrich, Claudia Diefenbach, Gisli Jenkins, Tamera J. Corte, Ian Glaspole, Mark Holmes, Lauren Troy, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Renaud Louis, Jan P. van Meerbeeck, Wim Wuyts, Radka Bittenglová, Vı́tězslav Kolek, Norbert Pauk, Pavel Reiterer, Martina Šterclová, Maritta Kilpeläinen, Riitta Mäkitaro, Marjukka Myllärniemi, Minna Purokivi, Terhi Rantala, Vincent Cottin, Françis Couturaud, Dominique Israëł-Biet, S. Jouneau, Romain Kessler, François Lebargy, S. Marchand‐Adam, Tom Bollmann, Andreas Günther, Peter Hammerl, J Kirschner, Anne‐Marie Kirsten, Michael Kreuter, Claus Neurohr, Antje Prasse, Nicolas Schönfeld, Rainer Wiewrodt, Attila Somfay, Balazs Medgyasszay, Eszter Csánky, György Losonczy, Hiroki Hayashi, Sakae Homma, Yoshikazu Inoue, Shinyu Izumi, Hideya Kitamura, Yasuhiko Nishioka, Osamu Nishiyama, Takashi Ogura, Masaki Okamoto, Takefumi Saito, Hiroyuki Taniguchi, Yoshiaki Zaizen, Marzena Filipowska, Agnieszka Jarzemska, Władysław Pierzchała, Wojciech Piotrowski, Krzysztof Sładek, Ewa Trawińska, Young Whan Kim, Jong Sun Park, Jin Woo Song, Myriam Aburto, Diego Castillo, José María Echave-Sustaeta, Christian Garcia Fadul, Susana Herrera, Jorge Moisés, María Molina‐Molina, Amália Moreno, Asunción Nieto, María Jesús Rodríguez‐Nieto, José Antonio Rodríguez-Portal, Belén Safont, Jacobo Sellarés, Claudia Valenzuela, Huzaifa Adamali, Nazia Chaudhuri, Michael Gibbons, Rachel K. Hoyles, Toby M. Maher, Helen Parfrey, Francis Averill, Steven Chambers, Neil Ettinger, G. Giessel, Lisa Jones, Mitchell Kaye

    Publicado em 2019
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

    Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants por Anna L. Peljto, Rachel Z. Blumhagen, Avram Walts, Jonathan Cardwell, Julia Powers, Tamera J. Corte, Joanne L. Dickinson, Ian Glaspole, Yuben Moodley, Martina Vašáková, Elisabeth Bendstrup, Jesper Rømhild Davidsen, Raphaël Borie, Bruno Crestani, Philippe Dieudé, Francesco Bonella, Ulrich Costabel, Gunnar Guðmundsson, Seamas C. Donnelly, Jim Egan, Michael T. Henry, Michael P. Keane, Marcus P. Kennedy, Cormac McCarthy, Aoife McElroy, Joshua A. Olaniyi, Katherine Ma O’Reilly, Luca Richeldi, Paolo Maria Leone, Venerino Poletti, Francesco Puppo, Sara Tomassetti, Valentina Luzzi, Nurdan Köktürk, Nesrin Moğulkoç, Christine Fiddler, Nikhil Hirani, Gisli Jenkins, Toby M. Maher, Philip L. Molyneaux, Helen Parfrey, Rebecca Braybrooke, Timothy S. Blackwell, Peter Jackson, Steven D. Nathan, Mary K. Porteous, Kevin K. Brown, Jason D. Christie, Harold R. Collard, Oliver Eickelberg, Elena Foster, Kevin F. Gibson, Marilyn K. Glassberg, Daniel J. Kass, Jonathan A. Kropski, David J. Lederer, A. Linderholm, James E. Loyd, Susan K. Mathai, Sydney B. Montesi, Imre Noth, Justin M. Oldham, Amy Palmisciano, Cristina Reichner, Mauricio Rojas, Jesse Roman, Neil W. Schluger, Barry S. Shea, Jeffrey J. Swigris, Paul J. Wolters, Yingze Zhang, Cecilia M. Prêle, Juan Ignacio Enghelmayer, María Otaola, Christopher J. Ryerson, Mauricio Salinas, Martina Šterclová, Tewodros Haile Gebremariam, Marjukka Myllärniemi, Roberto G. Carbone, Haruhiko Furusawa, Masaki Hirose, Yoshikazu Inoue, Yasunari Miyazaki, Ken Ohta, Shin Ohta, Tsukasa Okamoto, Dong Soon Kim, Annie Pardo, Moisés Selman, Alvaro U. Aranda, Moo Suk Park, Jong Sun Park, Jin Woo Song, María Molina‐Molina, Lurdes Planas‐Cerezales, Gunilla Westergren‐Thorsson, Albert V. Smith, Ani Manichaikul, John S. Kim

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: